Success Metrics

Clinical Success Rate
90.7%

Based on 78 completed trials

Completion Rate
91%(78/86)
Active Trials
12(9%)
Results Posted
21%(16 trials)
Terminated
8(6%)

Phase Distribution

Ph early_phase_1
9
7%
Ph not_applicable
48
37%
Ph phase_1
4
3%
Ph phase_2
16
12%
Ph phase_3
9
7%
Ph phase_4
39
30%

Phase Distribution

13

Early Stage

16

Mid Stage

48

Late Stage

Phase Distribution125 total trials
Early Phase 1First-in-human
9(7.2%)
Phase 1Safety & dosage
4(3.2%)
Phase 2Efficacy & side effects
16(12.8%)
Phase 3Large-scale testing
9(7.2%)
Phase 4Post-market surveillance
39(31.2%)
N/ANon-phased studies
48(38.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.6%

78 of 89 finished

Non-Completion Rate

12.4%

11 ended early

Currently Active

12

trials recruiting

Total Trials

129

all time

Status Distribution
Active(16)
Completed(78)
Terminated(11)
Other(24)

Detailed Status

Completed78
unknown21
Recruiting10
Terminated8
Suspended3
Withdrawn3

Development Timeline

Analytics

Development Status

Total Trials
129
Active
12
Success Rate
90.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 19 (7.2%)
Phase 14 (3.2%)
Phase 216 (12.8%)
Phase 39 (7.2%)
Phase 439 (31.2%)
N/A48 (38.4%)

Trials by Status

unknown2116%
active_not_recruiting22%
suspended32%
not_yet_recruiting22%
terminated86%
withdrawn32%
enrolling_by_invitation22%
completed7860%
recruiting108%

Recent Activity

Clinical Trials (129)

Showing 20 of 129 trialsScroll for more
NCT06802224Phase 4

The Choice of Vasopressor to Prevent Postoperative Acute Kidney Injury After Major Non-Cardiac Surgery

Recruiting
NCT02560805Phase 2

Role of Sympathetic Overactivity and Angiotensin II in PTSD and CV

Recruiting
NCT01731444Phase 1

Phenylephrine Tumescence for Hemostasis in Surgery for Burn Injury

Recruiting
NCT04777383Not Applicable

The Effects of Iontophoresed Vasoactive Drugs on Cutaneus Blood Flow

Terminated
NCT02673996

POTS Adrenergic Ab (CIHR Aims #1&2)

Recruiting
NCT06508359Not Applicable

Norepinephrine and Phenylephrine for Spinal Anesthesia-induced Hypotension.

Completed
NCT06648850Phase 2

Clinical Study of DA-001 as a Treatment for Hair Shedding Reduction and Hair Re-Growth

Not Yet Recruiting
NCT06083948Phase 2

Vasopressor Impact on Brain Circulation, Organ Blood Flow and Tissue Oxygenation During Anesthesia

Recruiting
NCT07327320Phase 4

Norepinephrine vs. Phenylephrine for Hypotension in Low-Dose Spinal Anesthesia for Cesarean Delivery

Completed
NCT02118467Phase 4

Vasoactive Drugs in Intensive Care Unit

Recruiting
NCT06053398Early Phase 1

Vasopressor Outcomes in Spine Surgery

Completed
NCT04789330Phase 4

Norepinephrine vs Phenylephrine During General Anesthesia

Completed
NCT02725060Not Applicable

Autoimmune Basis for Postural Tachycardia Syndrome

Enrolling By Invitation
NCT06158022Not Applicable

ED90 of Norepinephrine and Phenylephrine Infusions in Preeclamptic Patients

Completed
NCT07033845Early Phase 1

Pharmacokinetic Study of Topical Phenylephrine

Recruiting
NCT06741410

Ephedrine Versus Phenylephrine for Spinal Block - Related Hypotension in Cesarean Delivery

Completed
NCT04218773Early Phase 1

Blood PREssure Augmentation in Large-vessel Occlusion Stroke Study

Suspended
NCT04934748Phase 4

The GUARDIAN Trial - Vasopressor Sub-Study

Enrolling By Invitation
NCT06285396Not Applicable

Effect of Ephedrine, Phenylepinephrine, and Norepinephrine on Myometrial Contractility in Pregnant People With Type II and Gestational Diabetes During Cesarean Section: An In-vitro Study

Suspended
NCT04436731Early Phase 1

Sex Disparities in Hypoxic Sympatholysis and Impact of Obesity

Active Not Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
129